Operative Intensive Care News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail Uniklinik RWTH Aachen is the first hospital to implement SphingoTec s innovative biomarkers in clinical routine with the aim of making intensive care diagnostics more precise The biomarkers for the real-time assessment of kidney function (penKid®) and endothelial function (bio-ADM®) are pioneering new diagnostic pathways in critical care settings Following a positive initial clinical evaluation of penKid® and bio-ADM®, the University Hospital RWTH Aachen has transferred the innovative diagnostic tools into clinical routine The novel biomarkers enable a better diagnosis and monitoring of organ function Aachen, Germany and Hennigsdorf/Berlin, German, December 10, 2020 - The Uniklinik RWTH Aachen ( Uniklinik RWTH Aachen ) has successfully translated the collaboration for research and biomarker validation with SphingoTec GmbH ( SphingoTec ) into clinical routine. The routine measurements of the innovative biomarkers are providing organ-specific information for monit

San diegoUnited statesAndreas bergmannSphingotec gmbhGernot marxUniversity hospitalNexus dx incOperative intensive careIntermediate careEarly biomarkerSeptic acute kidney injurySeptic shockKidney int repGlobal burdenDisease studyVascular effects